2024-11-13T15:07:33+00:00

Eric Giesing Joins Savillex as Chief Executive Officer

Savillex is pleased to announce the appointment of Eric Giesing as Chief Executive Officer. An accomplished leader with broad expertise in life sciences, Giesing has previously held leadership positions during pivotal growth periods for numerous life sciences companies. He most recently served as Chief Commercial Officer at Fortis Life Science and has had a variety of management roles at Danaher Corporation.

Fill out my online form.
2103, 2022
  • Mike and Jodi Cleanroom

Savillex Life Sciences Revenue Experiences Massive Growth

By Eric Isberg - VP of Life Sciences Savillex Life Sciences Success: 10 Years in the Making You’ve probably heard the old cliche about “an overnight success…years in the making.” For our Purillex® brand of life science products, and the incredible growth surge we experienced in 2021, it has felt like

2103, 2022
  • Bottle Family

Three Ways Savillex Tests Container Closure Integrity

Container integrity is critical to product protection Testing for container integrity is key to ensuring containers are leak-free and can protect the critical process solutions and final products they contain. This testing is even more important in aseptic processes. That’s because container integrity can not only affect product sterility, but

2103, 2022
  • Lab tech with bottle

A Closer Look at Biological Contamination Testing

Creating contamination-free life science containers Container cleanliness is important for many life sciences applications. In fact, being simply “clean” isn’t enough. Containers need to be completely aseptic, meaning they are “free of contamination from bacteria, viruses or other microorganisms.”  Although sterilization processes like autoclaving and gamma irradiation can help eliminate

2502, 2022
  • Jars for tissue

What’s the Issue? This Is the Best Container for Tissues.

The Case for Jars in Tissue Processing  In tissue processing and transplantation, tissue engineering, and regenerative medicine, there’s a growing demand for appropriate-quality containers that can be used from R&D all the way through to product commercialization.  Quite often, containers used during the R&D phase are made from laboratory-grade materials

2402, 2022
  • James Vogel

New Technologies Demand Different Thinking. Can Bioprocess Evolve?

Can Bioprocessing Evolve to Meet a Rapidly Changing World? It’s a brave new world for the bioprocessing industry as groundbreaking new technologies - like cellular therapies and mRNA vaccines - emerge and hit the market at a blinding pace.  However, behind every one of these technological triumphs is complex manufacturing

102, 2022

Phacilitate Advanced Therapies Week 2022 Recap

By Drew Carlson, Applications Development Manager – Life Sciences Conversations and Collaboration Advanced Therapies Week, organized by Phacilitate, certainly gets a gold star from many attendees regarding their chosen location of Miami Beach. The warm weather is a welcome bonus in the heart of winter for many of the 300+

Go to Top